The challenge experiment using Redbiotec’s tetravalent influenza VLPs was successfully finalized. Results obtained clearly show that influenza VLPs are capable of stimulating the humoral and cellular immune responses which neutralize and inhibit replication of a challenge virus. When immunized mice were challenged with a lethal dose of the parental virus, 100% of mice were protected.